Is Cresco Labs a Risky Buy?
Cresco Labs (OTC: CRLBF) is looking to be one of the larger survivors in a cannabis industry that is going through a tumultuous phase.
The Chicago company's stock is down roughly 50% from where it was a year ago, and it has yet to turn a profit. However, Cresco saw significant revenue growth last quarter. With $68.6 million in cash, can the company last until it starts making money?
Source Fool.com